SD Biosensor, Inc.: Business Overview, Financials & Competitive Analysis
SD Biosensor, Inc. scores 7/10 on the AskCyborg Cyborg Score (Strong). Strong emerging-market positioned IVD player with diversified platform technology and expanding global footprint, benefiting from chronic disease screening and pandemic-related diagnostic demand. SD Biosensor demonstrates solid market positioning with ~$494M in trailing 12-month revenue and ~649 employees. The company benefits from established global distribution infrastructure, diverse product portfolio across.
What is SD Biosensor, Inc.'s industry? SD Biosensor, Inc. (sdbiosensor.com) operates in In-Vitro Diagnostics (IVD) - Medical Devices & Healthcare. AskCyborg classifies SD Biosensor, Inc. under In-Vitro Diagnostics (IVD) - Medical Devices & Healthcare in its company registry.
SD Biosensor is a global in-vitro diagnostic (IVD) company headquartered in Suwon, South Korea that designs, manufactures, and distributes point-of-care diagnostic solutions. The company provides comprehensive diagnos...
Cyborg Score thesis
Strong emerging-market positioned IVD player with diversified platform technology and expanding global footprint, benefiting from...
Read the full analyst-debate transcript →Get the Latest SD Biosensor, Inc. Report
Up-to-date AI-powered research, analyst debate audio & saved-company playlists
Get Current Report FreeSD Biosensor, Inc. Overview
Pro stress-test →SD Biosensor is a global in-vitro diagnostic (IVD) company headquartered in Suwon, South Korea that designs, manufactures, and distributes point-of-care diagnostic solutions. The company provides comprehensive diagnostic platforms spanning rapid immunochemical tests, molecular diagnostics, fluorescence immunoassay systems, and blood glucose monitoring devices for healthcare providers and patients globally.
Strategic Profile
Pro stress-test →SD Biosensor operates a diversified product portfolio including STANDARD Q (rapid diagnostics), STANDARD F (laboratory FIA systems), STANDARD M (point-of-care molecular diagnostics), and blood glucose monitoring solutions. The company maintains a strong international presence with subsidiaries across the USA, Brazil, Germany, Italy, Spain, India, and Indonesia, positioning itself as a leading global IVD provider serving both developed and low-to-middle income countries.
Competitive Landscape
Pro stress-test →SD Biosensor competes in the global IVD market against multinational giants (Abbott, Roche, Siemens, Bio-Rad) and regional players. The company differentiates through point-of-care solutions, emerging market focus, and platform technology. Competitive advantages include rapid product development, global distribution network, and lower-cost solutions suited for resource-constrained settings.
Industry Context
SD Biosensor, Inc. operates in In-Vitro Diagnostics (IVD) - Medical Devices & Healthcare.
Key facts
Founded: 2010 · Headquarters: Suwon, South Korea · Employees: 649 · Revenue: $494M · Market cap: $848M